Cardion AG, Erkrath, Germany 2008 Search

 Channels 14 Associated Channels

• Germany

  Germany is one the top 5 countries in Europe for the biotechnology industry. The €2 billion Innovative Medicines stimulus from the EU has helped, but that is spread over the continent. Over a d...

• Tuberculosis Vaccines and Therapeutics

  The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated inci...

• Vascular endothelial growth factor VEGF VEGF R

  The importance of tumor angiogenesis in tumor biology is now widely accepted and has emerged as a valid therapeutic target in oncology. Vascular endothelial growth factor (VEGF) represents a key med...

• Tumor Necrosis Factor TNF

  Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commercial...

• Sub-Saharan Africa

  Sub-Saharan Africa is a massive market for biotechnology companies with its collection of tropical diseases, large populations and agricultural importance. It is not only a customer in this industry...

Search Whole site using Google